US FDA places clinical hold on Iovance's lung cancer treatment trial

Iovance Biotherapeutics

27/12/2023 12:06

Dec 27 (Reuters) - Iovance Biotherapeutics  IOVA.O  said
on Wednesday that the U.S. Food and Drug Administration has
placed a clinical hold on its trial on a therapy for a type of
lung cancer. 

 (Reporting by Christy Santhosh; Editing by Shailesh Kuber)
 ((Christy.Santhosh@thomsonreuters.com;))